BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3195026)

  • 1. Single-dose treatment of neonatal calf pneumonia with the new macrolide antibiotic tilmicosin.
    Ose EE; Tonkinson LV
    Vet Rec; 1988 Oct; 123(14):367-9. PubMed ID: 3195026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica.
    Gourlay RN; Thomas LH; Wyld SG; Smith CJ
    Res Vet Sci; 1989 Jul; 47(1):84-9. PubMed ID: 2772410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting antibiotic formulations in the treatment of calf pneumonia: a comparative study of tilmicosin and oxytetracycline.
    Laven R; Andrews AH
    Vet Rec; 1991 Aug; 129(6):109-11. PubMed ID: 1926728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic disposition in experimental pneumonic pasteurellosis: gentamicin and tylosin.
    Burrows GE; Barto PB; Martin B
    Can J Vet Res; 1986 Apr; 50(2):193-9. PubMed ID: 3756673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives.
    Debono M; Willard KE; Kirst HA; Wind JA; Crouse GD; Tao EV; Vicenzi JT; Counter FT; Ott JL; Ose EE
    J Antibiot (Tokyo); 1989 Aug; 42(8):1253-67. PubMed ID: 2668243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of calf pneumonia with tilmicosin.
    Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A
    Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic efficacy of tilmicosin for bovine respiratory tract disease.
    Morck DW; Merrill JK; Thorlakson BE; Olson ME; Tonkinson LV; Costerton JW
    J Am Vet Med Assoc; 1993 Jan; 202(2):273-7. PubMed ID: 8428833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory benefits of tilmicosin in calves with Pasteurella haemolytica-infected lungs.
    Chin AC; Morck DW; Merrill JK; Ceri H; Olson ME; Read RR; Dick P; Buret AG
    Am J Vet Res; 1998 Jun; 59(6):765-71. PubMed ID: 9622749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimentally induced pneumonic pasteurellosis of young calves with tilmicosin.
    Morck DW; Merrill JK; Gard MS; Olson ME; Nation PN
    Can J Vet Res; 1997 Jul; 61(3):187-92. PubMed ID: 9242998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally administered tylosin for the control of pneumonia in neonatal calves.
    Matsuoka T; Muenster OA; Ose EE; Tonkinson L
    Vet Rec; 1980 Aug; 107(7):149-51. PubMed ID: 7445393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada.
    Hoar BR; Jelinski MD; Ribble CS; Janzen ED; Johnson JC
    Can Vet J; 1998 Mar; 39(3):161-6. PubMed ID: 9524721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tilmicosin and calf pneumonia.
    Mee JF; O'Farrell K
    Vet Rec; 1991 May; 128(19):460. PubMed ID: 1858280
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy evaluations of the use of oral tilmicosin in pneumonic calves.
    Fodor L; Reeve-Johnson L; Hodge A; Varga J
    Vet J; 2000 Mar; 159(2):194-200. PubMed ID: 10712808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves.
    Musser J; Mechor GD; Gröhn YT; Dubovi EJ; Shin S
    J Am Vet Med Assoc; 1996 Jan; 208(1):102-6. PubMed ID: 8682696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica.
    Goubau S; Morck DW; Buret A
    Can J Vet Res; 2000 Oct; 64(4):238-42. PubMed ID: 11041503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of tilmicosin in treatment of pulmonary infections in calves.
    Picavet T; Muylle E; Devriese LA; Geryl J
    Vet Rec; 1991 Nov; 129(18):400-3. PubMed ID: 1837391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of danofloxacin and tilmicosin on body temperatures of beef calves with pneumonia experimentally induced by inoculation with Mannheimia haemolytica.
    Fajt VR; Apley MD; Brogden KA; Skogerboe TL; Shostrom VK; Chin YL
    Am J Vet Res; 2004 May; 65(5):610-5. PubMed ID: 15141881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tilmicosin in a severe outbreak of respiratory disease in weaned beef calves.
    Scott PR; McGowan M; Sargison ND; Penny CD; Lowman BG
    Aust Vet J; 1996 Feb; 73(2):62-4. PubMed ID: 8660201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
    McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
    J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of experimentally induced Pasteurella haemolytica pneumonia on the pharmacokinetics of erythromycin in the calf.
    Burrows GE
    Am J Vet Res; 1985 Apr; 46(4):798-803. PubMed ID: 4014829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.